Hematology
Blood & lymphatic clinical trials
Anemia, clotting disorders, and other conditions of the blood and lymphatic system. We’re tracking 5,084 recruiting studies in this area right now.
By phase
- Not applicable2,111
- Phase 21,115
- Phase 1823
- Phase 1/Phase 2481
- Phase 3348
- Phase 4127
- Phase 2/Phase 379
Top conditions
- Multiple Myeloma332
- Acute Myeloid Leukemia292
- Lymphoma182
- Sickle Cell Disease140
- Myelodysplastic Syndromes129
- Acute Lymphoblastic Leukemia122
- Chronic Lymphocytic Leukemia100
- Leukemia100
- Follicular Lymphoma74
- Hematologic Malignancy68
- Myelodysplastic Syndrome68
- Hodgkin Lymphoma67
- Mantle Cell Lymphoma62
- Anemia60
- Diffuse Large B Cell Lymphoma57
- Lymphedema50
- Non-Hodgkin Lymphoma49
- Small Lymphocytic Lymphoma49
Leading sponsors
- Institute of Hematology & Blood Diseases Hospital, China148
- M.D. Anderson Cancer Center147
- National Cancer Institute (NCI)96
- The First Affiliated Hospital of Soochow University68
- Memorial Sloan Kettering Cancer Center64
- City of Hope Medical Center61
- Mayo Clinic61
- Assistance Publique - Hôpitaux de Paris46
- St. Jude Children's Research Hospital43
- Peking University People's Hospital41
Where studies are running
- California407
- Texas186
- Maryland149
- Alabama148
- Arizona124
- Florida110
- Massachusetts101
- New York98
- Ohio70
- Minnesota68
Recruiting studies5,084 total
- NCT06938542Enrolling by invitation
Palliative care needs for kids with rare diseases
This study asks children with rare diseases and their families about what kind of palliative care (comfort and support) they need. It aims to understand how to better help families through their child's illness.
Washington D.C., District of ColumbiaAges 1–99 - NCT06931613Enrolling by invitationPhase 2
STEM CELL TRANSPLANT FOR HODGKIN LYMPHOMA AFTER NIVOLUMAB
This trial tests a stem cell transplant using your own cells for children and teens with Hodgkin lymphoma that has come back or not gotten better after multiple treatments. It involves using a medicine called nivolumab before the transplant to help your body fight the cancer.
MoscowAges 2–18 - NCT06925685Enrolling by invitation
Long-term follow-up after CAR T-cell therapy
This study monitors participants who received a certain type of CAR T-cell therapy for cancer. It helps researchers understand long-term effects and safety.
Buffalo, New YorkAges Any age - NCT06902792Enrolling by invitationPhase 1
Adebrelimab and trametinib for children with hard-to-treat LCH
This trial tests a combination of two drugs for children and teens with Langerhans cell histiocytosis (LCH) that has not responded to standard treatments or has come back after treatment. The goal is to see if the drugs can shrink lesions and improve symptoms.
Wenzhou, ZhejiangAges Up to 18 years - NCT06900023Enrolling by invitation
Studying better ways to find breast swelling after cancer treatment
This trial looks at new tools to detect lymphedema (breast or arm swelling) after breast cancer treatment. If you had breast-conserving surgery, radiation, and have finished active therapy (except certain hormone treatments), researchers want to see if a simple device can spot fluid buildup early.
Boston, MassachusettsAges 18 years+ - NCT06848738Enrolling by invitation
Faster biopsy for lung cancer or lymphoma near the esophagus
This trial tests a faster way to get a tissue sample from lung cancer or lymphoma tumors that are near the esophagus or stomach. The goal is to start your treatment sooner by using a special ultrasound scope to do a biopsy right away.
NæstvedAges 18 years+ - NCT06831734Enrolling by invitation
Real-world safety study of Alhemo in hemophilia
This trial will track how well Alhemo works and how safe it is for people with hemophilia A or B in everyday use. If you are 12 or older and your doctor has already decided to start you on Alhemo, this study will collect information to help doctors better understand the medicine's real-world benefits and risks.
ChibaAges 12 years+ - NCT06827782Enrolling by invitationPhase 1
Cord blood CAR-NK cells for relapsed CNS lymphoma
This trial tests a new treatment using specially engineered immune cells from cord blood to target and kill cancer cells in the brain or spine. It is for people whose central nervous system lymphoma has not responded to or has returned after previous treatments.
Hangzhou, ZhejiangAges 18–75 - NCT06826209Enrolling by invitation
Comparing arm function in children with and without hemophilia
This study compares how well children with hemophilia use their arms and hands compared to healthy children. If your child has hemophilia A or B, is on regular treatment, and has no inhibitors or recent bleeds in the arm, they may be able to join.
Ankara, AnkaraAges 7–17 - NCT06816953Enrolling by invitation
Joint health in severe hemophilia A with prophylaxis
This study is looking at how well joint health can be tracked in people with severe hemophilia A who are receiving regular factor VIII treatment. It uses special markers in the blood and ultrasound to check for early joint changes.
Bangkok, PatumwanAges Any age - NCT06811740Enrolling by invitation
Treating severe asthma by focusing on key health issues
This trial looks at people with severe asthma that is hard to control. It aims to find and treat specific health problems that make asthma worse, by doing a detailed check-up and using treatments that are right for you.
Beijing, Beijing MunicipalityAges 18 years+ - NCT06756581Enrolling by invitation
Baked dairy trial for children with eosinophilic esophagitis
This trial tests whether children with eosinophilic esophagitis triggered by cow's milk can safely eat baked dairy foods. If you are in remission on a milk-free diet, you may be able to add baked milk products back into your diet.
JerusalemAges Up to 18 years - NCT06745817Enrolling by invitation
Nutrition study for women of childbearing age
This study looks at how well women in their reproductive years get enough nutrients from their diet. It will compare the nutrition of women who eat a regular diet, a vegetarian diet, or a vegan diet.
LjubljanaAges 20–49 - NCT06723015Enrolling by invitationPhase 2
Tau PET in anti-amyloid therapy for Alzheimer's
This study uses brain scans to see how anti-amyloid treatments affect tau protein buildup in people with early Alzheimer's. If you have mild cognitive impairment or mild Alzheimer's, you may be eligible to help understand how these treatments work.
Rochester, MinnesotaAges 50–90 - NCT06717932Enrolling by invitation
Long-term safety study of CS-101 injection
This study follows up with people who already received the CS-101 injection in a previous trial to check its safety and how well it works over time.
NanningAges 12–35 - NCT06711679Enrolling by invitationPhase 4
Finding the right dose of numbing medicine for lower body surgery
This study is testing different amounts and strengths of a numbing medicine called ropivacaine to find the best dose for blocking pain in the lower body during surgery. It may help patients need less pain medicine after surgery.
Wuhan, HubeiAges 1 day–7 years - NCT06697327Enrolling by invitation
Testing a three-drug combo for newly diagnosed AML
This trial tests a combination of three drugs—daunorubicin, cytarabine, and venetoclax—for people with newly diagnosed AML who are strong enough to receive intensive chemotherapy. The goal is to see if adding venetoclax helps improve treatment outcomes.
Hefei, AnhuiAges 18–59 - NCT06691464Enrolling by invitation
Using FAPI PET/CT to find lung scarring in non-healing ARDS
This study uses a special PET/CT scan to look for active scar tissue (fibrosis) in the lungs of people who are still very sick with ARDS after 5 days of ventilator support. It may help doctors understand why some lungs don't heal and could guide future treatments.
Groningen, Provincie GroningenAges 20 years+ - NCT06685536Enrolling by invitation
Long-term follow-up for CS-101 recipients
This study follows up on people who have already received the CS-101 infusion in a previous trial. It aims to check how participants are doing over time. There are no restrictions to join if you already received CS-101.
Nanning, GuangxiAges 6–35 - NCT06665490Enrolling by invitation
Skin care wash study for mycosis fungoides
This study tests whether a special skin care body wash can improve skin lesions in people with mycosis fungoides, a type of skin lymphoma. Researchers will look at skin bacteria before and after using the wash.
Chicago, IllinoisAges 18–89 - NCT06664541Enrolling by invitation
Gene therapy decisions and quality of life
This study looks at how people with blood diseases and their families make decisions about gene therapy, and how it affects their quality of life. It involves interviews or surveys to understand your experience.
Washington D.C., District of ColumbiaAges 18 years+ - NCT06652295Enrolling by invitation
Self-physiotherapy for lymphedema
This trial tests whether a self-guided physiotherapy program can help manage lymphedema (arm swelling) after breast cancer treatment. If you have had breast cancer-related lymphedema for a while and haven't had recent treatment for it, this study may offer a way to take control of your symptoms.
IzmirAges 18–65 - NCT06650358Enrolling by invitation
Outcomes for patients with LAL+ lens implants
This study looks at how the LAL+ lens implant performs in people who have had cataract surgery in both eyes and have completed light adjustments for the LAL+ lens. It aims to gather information on vision results and safety.
Wilkes-Barre, PennsylvaniaAges Any age - NCT06646978Enrolling by invitation
Long-term cancer risk in CML treatment trial
This study follows people who took part in the French SPIRIT trial for chronic myeloid leukemia (CML) to see if they develop other cancers later in life. It helps doctors understand the long-term safety of imatinib-based treatments.
PoitiersAges 18 years+
Common questions
- How many blood & lymphatic clinical trials are recruiting?
- Clin2 is tracking 5,084 recruiting hematology studies from the U.S. registry right now, out of 7,742 we cover in this area in total.
- What does “Blood & lymphatic” cover here?
- Anemia, clotting disorders, and other conditions of the blood and lymphatic system. We group each study into blood & lymphatic based on the conditions it studies, so you can scan the whole therapeutic area at once and drill into a specific condition.
- How do I find a blood & lymphatic trial near me?
- Use the search to filter blood & lymphatic studies by location and eligibility. Every Clin2 trial page explains the criteria in plain English and offers a short, optional pre-screen for a fit read — the study team makes the final decision.
Other specialties
- Cancer
- Brain & nervous system
- Heart & circulation
- Hormones & metabolism
- Mental health
- Digestive system
- Lungs & breathing
- Immune system & allergy
- Women’s health & pregnancy
- Skin
- Kidney & urinary
- Infections
- Genetic & congenital
- Bones, joints & muscles
- Pain
- Injuries & trauma
- Mouth & dental
- Eyes & vision
- Ear, nose & throat
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov; specialty groupings are derived from each study’s conditions. Talk with your doctor about whether a specific trial is right for you.